Business Standard

Wednesday, December 25, 2024 | 11:40 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Shot in the arm: Pharma sales clock double-digit growth in February

Amid Coronavirus fears, sales of antibiotics, paracetamol, and respiratory drugs see a spike

pharma, medicines, drugs
Premium

Overall, February’s growth rate was led by prices that grew by 5.4 per cent, followed by volumes (3.8 per cent) and new products at 2.9 per cent.

Sohini Das Mumbai
The domestic pharmaceutical market recovered in February. It clocked 12.1 per cent growth, riding on higher demand for respiratory medicines and antibiotics. 

In the past two months, the market was registering single-digit growth — 7.7 per cent in January and 8.8 per cent in December. The growth was essentially led by therapies like respiratory (which saw the highest growth of 17.9 per cent), followed by anti-infectives (clocking 14.1 per cent growth) and cardiac at 13.3 per cent. In fact, eight of the top 10 therapies in the domestic market have registered a growth of over 10 per cent. 

Overall, February’s

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in